{"id":"transfusion-of-blood-products","safety":{"commonSideEffects":[{"rate":"0.01-0.1","effect":"Transfusion reaction (acute hemolytic)"},{"rate":"0.5-3","effect":"Febrile non-hemolytic transfusion reaction"},{"rate":"1-3","effect":"Allergic reaction"},{"rate":"0.02-0.1","effect":"Transfusion-related acute lung injury (TRALI)"},{"rate":"varies by product and screening","effect":"Infection (bacterial, viral)"},{"rate":null,"effect":"Iron overload (with chronic transfusion)"},{"rate":"1-5","effect":"Alloimmunization"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Blood product transfusion replaces lost or deficient blood components including red blood cells (oxygen transport), platelets (hemostasis), plasma (coagulation factors), and whole blood. This restores hemodynamic stability, tissue oxygenation, and hemostatic function in patients with acute blood loss, chronic anemia, or acquired or congenital coagulation disorders.","oneSentence":"Transfusion of blood products restores circulating blood volume, oxygen-carrying capacity, and clotting factors to treat hemorrhage, anemia, or coagulopathy.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:13:53.879Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute hemorrhage and hypovolemic shock"},{"name":"Severe anemia"},{"name":"Thrombocytopenia or platelet dysfunction"},{"name":"Coagulopathy and clotting factor deficiency"}]},"trialDetails":[{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07466719","phase":"NA","title":"Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage","status":"RECRUITING","sponsor":"Aswan University","startDate":"2025-09-01","conditions":"Obstetric Hemostasis, Intravascular Hemolysis, Major Obstetric Hemorrhage","enrollment":50},{"nctId":"NCT07437755","phase":"NA","title":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","status":"RECRUITING","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2025-06-01","conditions":"Liver Cirrhosis With Acute Decompensation","enrollment":116},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07366606","phase":"NA","title":"Bleeding Management İn Open Heart Surgery","status":"NOT_YET_RECRUITING","sponsor":"Serkan Uckun","startDate":"2026-04","conditions":"Thromboelastography (TEG), Open Heart Surgery, Bleeding","enrollment":140},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT07265674","phase":"PHASE3","title":"A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer","status":"RECRUITING","sponsor":"J-Pharma Co., Ltd.","startDate":"2026-01","conditions":"Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)","enrollment":480},{"nctId":"NCT06147531","phase":"PHASE2","title":"Delayed Cold-Stored Platelets -PLTS-1","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06-05","conditions":"Platelets, Bleeding, Cardiopulmonary Bypass","enrollment":150},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT07121140","phase":"NA","title":"Home Blood Transfusions","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-06-03","conditions":"Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT06285604","phase":"","title":"Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2024-09-10","conditions":"Neonatal Anemia","enrollment":200},{"nctId":"NCT04540380","phase":"PHASE1","title":"Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-09-01","conditions":"Renal Failure","enrollment":20},{"nctId":"NCT05466201","phase":"PHASE2, PHASE3","title":"The Use of Eltrombopag Post HSCT in BMFD","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-10-22","conditions":"Stem Cell Transplant Complications","enrollment":118},{"nctId":"NCT04879485","phase":"NA","title":"Prehospital Transfusion Strategy in Bleeding Patients","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2021-05-03","conditions":"Hemorrhage, Blood Component Transfusion","enrollment":120},{"nctId":"NCT04922307","phase":"NA","title":"Reduction of Allogenic Blood Transfusion in Locally Advanced Kidney Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2021-07-23","conditions":"Kidney Cancer","enrollment":240},{"nctId":"NCT07225374","phase":"PHASE2","title":"Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-09-16","conditions":"Upper Tract Urothelial Carcinoma","enrollment":48},{"nctId":"NCT06749405","phase":"NA","title":"Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-03-08","conditions":"Liver Transplantation","enrollment":56},{"nctId":"NCT05638581","phase":"PHASE3","title":"Trauma Resuscitation With Low-Titer Group O Whole Blood or Products","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2023-07-27","conditions":"Wounds and Injuries, Shock, Hemorrhagic","enrollment":1100},{"nctId":"NCT06809010","phase":"NA","title":"grouP O wholE blooD : storagE leSion impacT And infLammation","status":"RECRUITING","sponsor":"Etablissement Français du Sang","startDate":"2025-03-12","conditions":"Blood Donation, Blood Platelets, Blood Donors","enrollment":30},{"nctId":"NCT06259734","phase":"NA","title":"Transfusion Camp for Medical Students in Rwanda","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2024-05-06","conditions":"Global Health, Medical Education","enrollment":150},{"nctId":"NCT07064954","phase":"PHASE2, PHASE3","title":"Autologous Cold-stored Apheresis Platelets","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-01","conditions":"Bleeding, Platelets, Cardiopulmonary Bypass","enrollment":100},{"nctId":"NCT06820879","phase":"NA","title":"Viscoelastic Tests (VET) Versus Conventional Coagulation Tests (CCT) for Management of Trauma-Induced Coagulopathy","status":"NOT_YET_RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-10-01","conditions":"Trauma Coagulopathy","enrollment":316},{"nctId":"NCT06483269","phase":"NA","title":"Homologus PRP in the Infiltrative Treatment of Knee Osteoarthritis in Young Athletic Patients","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2023-10-10","conditions":"Knee Osteoarthritis","enrollment":30},{"nctId":"NCT06240117","phase":"NA","title":"Impact of Intraoperative Cell Salvage","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-03-11","conditions":"Peripartum Anemia","enrollment":20},{"nctId":"NCT06831565","phase":"NA","title":"Comparison of Blood Products Required Using Two Different ROTEM Cut-offs Before Invasive Procedures in Cirrhosis and Acute on Chronic Liver Failure (ACLF) Patients With Severe Coagulopathy","status":"RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2025-03-19","conditions":"Acute-On-Chronic Liver Failure","enrollment":934},{"nctId":"NCT06425614","phase":"NA","title":"COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial","status":"RECRUITING","sponsor":"University Hospital, Bordeaux","startDate":"2024-07-15","conditions":"On-pump Cardiac Surgery, High Risk for Bleeding, Autotransfusion","enrollment":570},{"nctId":"NCT07005661","phase":"PHASE2, PHASE3","title":"Use of PRP in Open Surgery for Type A Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-06-30","conditions":"Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP)","enrollment":250},{"nctId":"NCT05814094","phase":"NA","title":"Red Blood Cell Transfusion in ECMO - A Feasibility Trial","status":"RECRUITING","sponsor":"Australian and New Zealand Intensive Care Research Centre","startDate":"2023-09-20","conditions":"Blood Loss Anemia, Extracorporeal Membrane Oxygenation Complication, Disability Physical","enrollment":120},{"nctId":"NCT02887820","phase":"NA","title":"Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)","status":"TERMINATED","sponsor":"Stephen Esper","startDate":"2017-12-15","conditions":"Heart Disease, Lung Disease","enrollment":15},{"nctId":"NCT04201704","phase":"NA","title":"Effect of Giving Reduced Fluid in Children After Trauma","status":"RECRUITING","sponsor":"Columbia University","startDate":"2018-08-27","conditions":"Critical Illness, Pediatrics, General Surgery","enrollment":250},{"nctId":"NCT06553833","phase":"","title":"Outcomes of Patient Blood Management in Patients Undergoing Major Surgery","status":"COMPLETED","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-09-01","conditions":"Major Surgery","enrollment":25979},{"nctId":"NCT05634005","phase":"NA","title":"Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-02-01","conditions":"Anemia, Thrombocytopenia, Coagulopathy, Mild","enrollment":1543},{"nctId":"NCT05634109","phase":"PHASE3","title":"Whole Blood in Trauma Patients With Hemorrhagic Shock","status":"RECRUITING","sponsor":"Fundacion Clinica Valle del Lili","startDate":"2023-01-14","conditions":"Trauma, Trauma Injury, Trauma, Multiple","enrollment":220},{"nctId":"NCT04704869","phase":"PHASE3","title":"Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation","status":"COMPLETED","sponsor":"Bryan Cotton","startDate":"2017-01","conditions":"Trauma Injury","enrollment":1604},{"nctId":"NCT05667805","phase":"PHASE4","title":"Coagulation in Cirrhosis","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-01-19","conditions":"Liver Cirrhosis","enrollment":400},{"nctId":"NCT03204357","phase":"NA","title":"Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2022-01-24","conditions":"Cardiac Disease, Bleeding Postoperative","enrollment":70},{"nctId":"NCT06680180","phase":"","title":"Fibrinolysis Resistance in Infection and Trauma","status":"RECRUITING","sponsor":"Anders Aneman","startDate":"2024-06-01","conditions":"Sepsis and Septic Shock, Trauma","enrollment":150},{"nctId":"NCT01019876","phase":"PHASE2, PHASE3","title":"Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases","status":"COMPLETED","sponsor":"Columbia University","startDate":"2002-09","conditions":"Bone Marrow Failure, Osteopetrosis, Fanconi Anemia","enrollment":38},{"nctId":"NCT04776850","phase":"EARLY_PHASE1","title":"Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-12-29","conditions":"Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia","enrollment":""},{"nctId":"NCT04859218","phase":"NA","title":"Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?","status":"RECRUITING","sponsor":"McMaster University","startDate":"2023-10-17","conditions":"Myelodysplastic Syndrome","enrollment":30},{"nctId":"NCT06593301","phase":"NA","title":"The Effect of Blood and Blood Products Transfusion Training Based on the Flipped Classroom Model on Nursing Students","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-02-21","conditions":"Self-efficacy","enrollment":85},{"nctId":"NCT04760977","phase":"","title":"Prehospital Management of Hypotensive Trauma in HEMS","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2021-05-01","conditions":"Hypotension and Shock, Wounds and Injuries, Emergencies","enrollment":500},{"nctId":"NCT06542185","phase":"NA","title":"Self-Efficacy Levels of Nurses on Safe Blood and Blood Product Transfusion","status":"COMPLETED","sponsor":"Yuksek Ihtisas University","startDate":"2024-05-20","conditions":"To Evaluate the Effect of Online Education on Nurses' Self-efficacy Regarding Blood Transfusion","enrollment":90},{"nctId":"NCT06519344","phase":"EARLY_PHASE1","title":"An Exploratory Clinical Study Evaluating the Safety and Efficacy of Intravenous Anti-CD20/CD30-CAR-T Cell Infusion in Relapsed/Refractory Lymphoma Patients.","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Tongji Hospital, Tongji University School of Medicine","startDate":"2024-07-31","conditions":"B Cell Malignancies","enrollment":12},{"nctId":"NCT02729974","phase":"NA","title":"Use of ROTEM Intraoperatively in Women With Placenta Accreta","status":"ENROLLING_BY_INVITATION","sponsor":"University of Utah","startDate":"2016-05-08","conditions":"Placenta Accreta","enrollment":40},{"nctId":"NCT05771831","phase":"PHASE2","title":"Thrombosomes® in Acute Thoracic Aortic Dissections","status":"COMPLETED","sponsor":"Jakob Stensballe, MD, PhD","startDate":"2023-03-15","conditions":"Thoracic Aortic Dissection","enrollment":41},{"nctId":"NCT06375161","phase":"EARLY_PHASE1","title":"Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.","status":"RECRUITING","sponsor":"Shanghai Tongji Hospital, Tongji University School of Medicine","startDate":"2023-12-11","conditions":"B Cell Malignancies","enrollment":12},{"nctId":"NCT04439968","phase":"NA","title":"Neonatal Brain Oxygenation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stanford University","startDate":"2021-08-10","conditions":"Cerebral Hypoxia","enrollment":100},{"nctId":"NCT05583539","phase":"NA","title":"Thromboelastography Guided Blood Product Transfusion for Upper Gastrointestinal Bleeding in Cirrhosis","status":"WITHDRAWN","sponsor":"Vanderbilt University Medical Center","startDate":"2025-01-16","conditions":"Cirrhosis, Liver, Coagulopathy, GastroIntestinal Bleeding","enrollment":""},{"nctId":"NCT06345417","phase":"","title":"Outcomes of Patient Blood Management in Severely Anemic Patients","status":"NOT_YET_RECRUITING","sponsor":"Helios Klinik Gotha/Ohrdruf","startDate":"2024-04-01","conditions":"Severe Anemia","enrollment":20000},{"nctId":"NCT06325553","phase":"","title":"Incidence of Platelet Refractoriness in Adult Acute Leukemia Patients Receiving Prestorage Filtered Blood and Comparing With Historical Control","status":"RECRUITING","sponsor":"Siriraj Hospital","startDate":"2024-03-30","conditions":"Platelet Refractoriness in Adult Acute Leukemia","enrollment":252},{"nctId":"NCT03727230","phase":"NA","title":"RhD+ Blood Transfusion to Asian-type DEL Recipients","status":"COMPLETED","sponsor":"Guangzhou Blood Center","startDate":"2016-10-01","conditions":"Blood Transfusion, Rhesus Isoimmunisation Due to Anti-D, Blood Group Antigen Abnormality","enrollment":54},{"nctId":"NCT04020224","phase":"NA","title":"INTERCEPT Safety Evaluation on Whole Blood","status":"WITHDRAWN","sponsor":"Swiss Transfusion SRC","startDate":"2024-01","conditions":"Safety Issues","enrollment":""},{"nctId":"NCT06285656","phase":"","title":"Femoral Blood Gas and Prediction of Postoperative Bleeding","status":"UNKNOWN","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-03-01","conditions":"Postoperative Hemorrhage, Blood Transfusion","enrollment":100},{"nctId":"NCT03932240","phase":"PHASE3","title":"In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)","status":"COMPLETED","sponsor":"Emory University","startDate":"2019-08-13","conditions":"Hemostasis","enrollment":36},{"nctId":"NCT06136715","phase":"","title":"Massive Transfusion in Trauma Patient Registry","status":"UNKNOWN","sponsor":"Methodist Health System","startDate":"2023-07-13","conditions":"Trauma","enrollment":500},{"nctId":"NCT06128057","phase":"","title":"Comparing TASH Score and Modified TBSS in Trauma Patients in Need for Massive Blood Transfusion","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-12-05","conditions":"Massive Blood Transfusion in Trauma Patients","enrollment":140},{"nctId":"NCT06084351","phase":"PHASE3","title":"Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection","status":"WITHDRAWN","sponsor":"Larkin Community Hospital","startDate":"2020-05-12","conditions":"Covid19","enrollment":""},{"nctId":"NCT03096782","phase":"PHASE2","title":"Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-10-13","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia","enrollment":6},{"nctId":"NCT00471848","phase":"PHASE2","title":"Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia","status":"COMPLETED","sponsor":"European Society for Blood and Marrow Transplantation","startDate":"2008-08","conditions":"Aplastic Anemia","enrollment":35},{"nctId":"NCT05986734","phase":"","title":"Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies","status":"UNKNOWN","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2022-09-01","conditions":"Primary Immunodeficiency Diseases (PID)","enrollment":100},{"nctId":"NCT02972593","phase":"PHASE4","title":"ORthopaedic Trauma Anemia With Conservative Versus Liberal Transfusion","status":"COMPLETED","sponsor":"Indiana University","startDate":"2014-03","conditions":"Anemia","enrollment":161},{"nctId":"NCT04823273","phase":"NA","title":"Blood Transfusion Reduction - QI Project","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2021-04-06","conditions":"Blood Transfusion","enrollment":1640},{"nctId":"NCT02745717","phase":"PHASE4","title":"The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2016-01","conditions":"Severe Aplastic Anemia","enrollment":60},{"nctId":"NCT04814264","phase":"EARLY_PHASE1","title":"Pilot Study of Sex-matched vs. Sex-mismatched Red Blood Cell Transfusion","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-01-07","conditions":"Blood Transfusion","enrollment":270},{"nctId":"NCT03302195","phase":"NA","title":"Optimal Cardiopulmonary Bypass and Anticoagulation Management Strategies in Obese Patients Undergoing Cardiac Surgery","status":"RECRUITING","sponsor":"Laval University","startDate":"2015-08-21","conditions":"Cardiopulmonary Bypass, Obesity","enrollment":410},{"nctId":"NCT04668248","phase":"NA","title":"Novel Application of Simulation for Providers to Overcome Decisional Gaps in High-risk Prescribing","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2021-03-29","conditions":"Medication Administered in Error, Antipsychotics and Neuroleptics Toxicity","enrollment":47},{"nctId":"NCT05708690","phase":"PHASE4","title":"Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery","status":"COMPLETED","sponsor":"Indonesia University","startDate":"2022-10-01","conditions":"Coronary Artery Disease, Valvular Heart Disease, Surgical Blood Loss","enrollment":132},{"nctId":"NCT05698134","phase":"NA","title":"Rotational Thromboelastometry (ROTEM™) Guided Transfusion for Elective Procedures in Patients With Cirrhosis (REduCe): An Open Label Randomized Controlled Trial.","status":"UNKNOWN","sponsor":"Changi General Hospital","startDate":"2021-08-01","conditions":"Cirrhosis, Liver","enrollment":74},{"nctId":"NCT02088541","phase":"PHASE2","title":"Selinexor (KPT-330) in Older Patients With Relapsed AML","status":"COMPLETED","sponsor":"Karyopharm Therapeutics Inc","startDate":"2014-03","conditions":"Acute Myeloid Leukemia (AML)","enrollment":317},{"nctId":"NCT02819960","phase":"PHASE3","title":"Prevention of Irinotecan Induced Diarrhea by Probiotics","status":"COMPLETED","sponsor":"S&D Pharma SK s.r.o.","startDate":"2016-03","conditions":"Diarrhea, Cancer","enrollment":233},{"nctId":"NCT05607940","phase":"PHASE2, PHASE3","title":"Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-01","conditions":"Blood Transfusion","enrollment":260},{"nctId":"NCT01730118","phase":"PHASE1","title":"Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-03-04","conditions":"Breast Neoplasms, Breast Cancer, Adenocarcinomas","enrollment":33},{"nctId":"NCT05501730","phase":"","title":"Use of the Quantra QPlus Sytem in Cardiac Surgery","status":"COMPLETED","sponsor":"HemoSonics LLC","startDate":"2021-06-15","conditions":"Cardiovascular Diseases","enrollment":128},{"nctId":"NCT03344887","phase":"PHASE4","title":"An Innovative Trial Assessing Donor Sex on Recipient Mortality","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2018-09-04","conditions":"Red Blood Cell Transfusion","enrollment":8850},{"nctId":"NCT04609228","phase":"","title":"Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-10-30","conditions":"Thoracic Surgery, Blood Transfusion; Hemoglobinemia, Cardiac Disease","enrollment":1911},{"nctId":"NCT04804345","phase":"","title":"AProtinin Versus Tranexamic Acid in Cardiac Surgery Patients With High-risk for Excessive Bleeding","status":"COMPLETED","sponsor":"University Hospital, Bordeaux","startDate":"2021-03-31","conditions":"Cardiac Surgery, Cardiopulmonary Bypass, High Risk Bleeding","enrollment":693},{"nctId":"NCT00305344","phase":"PHASE1, PHASE2","title":"Umbilical Cord Blood Infusion to Treat Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Florida","startDate":"2005-04","conditions":"Type 1 Diabetes Mellitus","enrollment":23},{"nctId":"NCT02784951","phase":"","title":"Use of Blood and Plasma in Norwegian Physician-staffed Helicopter Emergency Medical System","status":"COMPLETED","sponsor":"Haukeland University Hospital","startDate":"2016-01-01","conditions":"Hemorrhagic Shock","enrollment":72},{"nctId":"NCT05075915","phase":"","title":"Transfusion and COVID-19","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-09-01","conditions":"COVID-19","enrollment":500},{"nctId":"NCT04405518","phase":"PHASE4","title":"Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.","status":"UNKNOWN","sponsor":"Antoni Sabaté Pes","startDate":"2019-06-17","conditions":"Fibrin Blood Clot","enrollment":188},{"nctId":"NCT05063409","phase":"NA","title":"Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting","status":"COMPLETED","sponsor":"Shriners Hospitals for Children","startDate":"2010-09","conditions":"Burn Injury","enrollment":72},{"nctId":"NCT04610814","phase":"","title":"Blood Transfusion by Boston MedFlight Registry","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2019-11-01","conditions":"Hemorrhagic Shock","enrollment":500},{"nctId":"NCT03128658","phase":"","title":"Trauma Induced Coagulopathy and Inflammation","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2017-02-27","conditions":"Trauma Injury, Trauma, Coagulopathy","enrollment":300},{"nctId":"NCT03999086","phase":"","title":"Thromboelastography-Guided Fluid Management in Spinal Surgery","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-01-12","conditions":"Spinal Fusion","enrollment":50},{"nctId":"NCT00017550","phase":"PHASE2","title":"Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome","status":"COMPLETED","sponsor":"Genzyme, a Sanofi Company","startDate":"2000-09","conditions":"Myelodysplastic Syndromes","enrollment":""},{"nctId":"NCT02457403","phase":"NA","title":"Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2015-05","conditions":"Cirrhosis, Coagulopathy","enrollment":68},{"nctId":"NCT02473666","phase":"","title":"Patient Blood Management - Use and Outcome","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2012-01","conditions":"Hemorrhage","enrollment":250000},{"nctId":"NCT02577614","phase":"PHASE1","title":"FEIBA and Use of Blood Products in Cardiac Surgery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2016-02","conditions":"Cardiovascular Disease","enrollment":12},{"nctId":"NCT01490723","phase":"PHASE2","title":"Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-01","conditions":"Leukemia, Lymphoma","enrollment":20},{"nctId":"NCT00176852","phase":"PHASE2, PHASE3","title":"Stem Cell Transplant for Hemoglobinopathy","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-06","conditions":"Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia","enrollment":22},{"nctId":"NCT02083549","phase":"","title":"Evaluating URMC's Massive Transfusion Protocol","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2013-04","conditions":"Blood Coagulation Disorders, Trauma, Acute Coagulopathy","enrollment":2},{"nctId":"NCT02461251","phase":"NA","title":"Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients","status":"COMPLETED","sponsor":"Tampere University Hospital","startDate":"2016-01","conditions":"Obstetric Labor Complications, Hemorrhage","enrollment":59},{"nctId":"NCT01829503","phase":"PHASE2","title":"Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)","status":"COMPLETED","sponsor":"Annie Im, M.D.","startDate":"2013-02","conditions":"Acute Myeloid Leukemia","enrollment":44},{"nctId":"NCT03291769","phase":"","title":"Effects of Intraoperative Blood and Blood Product Consumption on Postoperative Results in Pediatric Cardiac Surgery","status":"COMPLETED","sponsor":"Cukurova University","startDate":"2018-03-25","conditions":"Blood Loss, Surgical, Pediatric Heart Surgery","enrollment":83},{"nctId":"NCT03446638","phase":"NA","title":"iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2019-05","conditions":"Myelodysplastic Syndromes","enrollment":""},{"nctId":"NCT01611935","phase":"PHASE2","title":"AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2013-05-01","conditions":"Traumatic Shock","enrollment":101},{"nctId":"NCT03468738","phase":"","title":"Investigation of the Transfusion Practices in Surgical Patients in Turkey","status":"COMPLETED","sponsor":"Diskapi Teaching and Research Hospital","startDate":"2018-04-02","conditions":"Surgery, Blood Loss, Surgical, Blood Loss Anemia","enrollment":6481}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":857,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Transfusion of blood products","genericName":"Transfusion of blood products","companyName":"Fundacion Clinica Valle del Lili","companyId":"fundacion-clinica-valle-del-lili","modality":"Biologic","firstApprovalDate":"","aiSummary":"Transfusion of blood products restores circulating blood volume, oxygen-carrying capacity, and clotting factors to treat hemorrhage, anemia, or coagulopathy. Used for Acute hemorrhage and hypovolemic shock, Severe anemia, Thrombocytopenia or platelet dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}